Aboghanem Abdelhamid, Prasad G V Ramesh
School of Medicine, University of Toronto, Toronto M5C 2T2, Ontario, Canada.
Kidney Transplant Program, St. Michael's Hospital, Toronto M5C 2T2, Ontario, Canada.
World J Transplant. 2024 Sep 18;14(3):95905. doi: 10.5500/wjt.v14.i3.95905.
Disturbances of potassium balance are often encountered when managing kidney transplant recipients (KTR). Both hyperkalemia and hypokalemia may present either as medical emergencies or chronic outpatient abnormalities. Despite the high incidence of hyperkalemia and its potential life-threatening implications, consensus on its management in KTR is lacking. Hypokalemia in KTR is also well-described, although it is given less attention by clinicians compared to hyperkalemia. This article discusses the etiology, pathophysiology and management of both types of potassium disorders in KTR. Once any emergent situation has been corrected, treatment approaches include correcting insulin deficiency if present, adjusting non-immunosuppressive and immunosuppressive medications, eliminating or supplementing potassium as needed, and dietary counselling. Although commonly of multifactorial etiology, ascertaining the specific cause in a particular patient will help guide successful management. Monitoring KTR through regular laboratory testing is essential to detect serious disturbances in potassium balance since patients are often asymptomatic.
在管理肾移植受者(KTR)时,经常会遇到钾平衡紊乱的情况。高钾血症和低钾血症既可能表现为医疗急症,也可能表现为慢性门诊异常情况。尽管高钾血症的发生率很高,且具有潜在的危及生命的影响,但在KTR患者中对其治疗仍缺乏共识。KTR患者中的低钾血症也有详细描述,不过与高钾血症相比,临床医生对它的关注较少。本文讨论了KTR患者中这两种钾紊乱的病因、病理生理学及治疗方法。一旦纠正了任何紧急情况,治疗方法包括:如有胰岛素缺乏则予以纠正,调整非免疫抑制药物和免疫抑制药物,根据需要消除或补充钾,并提供饮食咨询。尽管病因通常是多因素的,但确定特定患者的具体病因将有助于指导成功的治疗。由于患者通常没有症状,通过定期实验室检测对KTR患者进行监测对于发现严重的钾平衡紊乱至关重要。